AUTHORS

Christopher Michael Copeland

Dr Christopher Copeland was the owner and Scientific Director of Canberra Fertility Centre until May 2016 when the centre was sold to Virtus Health Ltd. Dr Copeland continued as Business Manager at the renamed IVF Australia (Canberra) until June 2019 when he became the chairman of RTAC.

Professional Training:

Chairman of RTAC 2019 – present

Scientists in Reproductive Technology representative to RTAC 2016- 2019

Technical assessor NATA 2016-present

Business Manager IVF Australia (Canberra) 2016-2019

Scientific Director Canberra Fertility Centre ACT 1992-2016

Scientific Director Fertility East, Bondi Junction NSW. 2006-2014

Scientific Director Fertility North, Joondalup Western Australia 2005-2012

Assistant Scientific Director Concept Fertility Centre WA 1987-1991

Laboratory Manager Cohen’s Private Pathology WA 1985-1986

Senior Scientific Officer Radio Immunoassay, Cohen’s Private Pathology WA 1981-1984

PhD (thesis) University of WA 1980

BSc Honors (first class) University of WA 1976

Membership of Societies:

Member Scientists in Reproductive Technology
Member Fertility Society of Australia
Member American Society of Reproductive Medicine
Member Australasian Society of Clinical Biochemistry
Member European Society for Human Reproduction

Current Research/Activities

AMH Measurements as a guide to FSH dosage in Stimulated ART cycles.

DNA fragmentation and pregnancy outcome

Publications:

Liu, Y., et al. (2015). “The relationship between embryo quality assessed using routine embryology or time–lapse videography and serum progesterone concentration on the day of ovulatory trigger in in vitro fertilization cycles.” Asian Pacific Journal of Reproduction 4(2): 140-146.

Liu, Y., et al. (2015). “Assessment of human embryos by time-lapse videography: A comparison of quantitative and qualitative measures between two independent laboratories.” Reproductive Biology 15(4): 210-216.

Stafford-Bell, M. A. and C. M. Copeland (2001). “Surrogacy in Australia: implantation rates have implications for embryo quality and uterine receptivity.” Reproduction, Fertility and Development 13(1): 99-104.

Selley, M. L., et al. (1991). “Content of significant amounts of a cytotoxic end-product of lipid peroxidation in human semen.” Journal of Reproduction and Fertility 92(2): 291-298.

Bellinge, B. S., et al (1986). “The influence of patient insemination on the implantation rate in an in vitro fertilization and embryo transfer program.” Fertility and Sterility 46(2): 252-256.

Presentations:

Copeland, C., (November 2018.) “Regulation of ART.” Start-up Training in Assisted Reproductive Technology. Melbourne.

Copeland, C., (May 2015.) “Oocyte and embryo assessment- picking the winners and losers.” Weekend SIRT meeting, Perth.

Copeland, C., et al. (September 2013.) “A comparison of men’s responses to surgical sperm retrieval with women’s responses to transvaginal oocyte retrieval for in-vitro fertilization (IVF).” Fertility Society of Australia, Annual conference, Sydney. Poster presentation.

Copeland, C., (July 2013.) “Take home baby: Egg number V’s egg quality – a statistical take.” Fertility Nurses Australia(NSW), annual meeting, Sydney.

Copeland, C., and Robson, S., (August 2012.) “IVF Live Births Rates per Oocyte Retrieval.” Australian National University, Canberra Hospital Scientific Day, Poster presentation.

Copeland, C., (May 2012.) “Ultrasound and Biochemistry of PCOS.” Australian Sonographers Association annual meeting, Canberra.

Copeland, C., (April 2008.) “Lessons for Setting up an ART Laboratory.” SIRT annual meeting. Brisbane.

Copeland, C., et al. (October 2006.) “ART Laboratory Requirements.” Chinese Government Delegation, John James Hospital, Canberra.

Copeland, C., (October 2006.) “An Update on ART.” ASAM, annual meeting, Canberra.

Copeland, C., (June 2005.) “ Polycystic Ovaries.” PCO Association Annual Meeting,

Copeland, C., (May 2001.) “Blastocyst Culture.” ACT Patient Support Group, Canberra.

Copeland, C., (October 1999.) “Experience with Assisted Hatching using the Fertilase Micro Surgical Laser.” SIRT Annual Meeting.

Copeland, C., and Stafford-Bell, M., (May 1999.) “Results from Australia’s first Legalized Surrogacy Program.” 11th World Congress on In Vitro Fertilization and Human Reproductive Genetics, Poster Presentation 167.

Copeland, C., et al. (May 1999.) “Counseling of Participants in the ACT Surrogacy Program.” 11th World Congress on In Vitro Fertilization and Human Reproductive Genetics, Oral Presentation 186.

Copeland, C., (November 1998.) “Ovulation in the Human Female – A Biochemical Perspective.” ACS-180 Users Group NSW Division.

Copeland, C., (October 1996.) “The Process of Oogenesis.” Family Planning Association (ACT)

Copeland, C., (August 1996). “Estrad-6: A New Assay for 17-Estradiol using the ACS-180.” ACS-180 Users Group NSW Division.

Copeland, C., (March 1995). “Causes and Treatments for Infertility.” Family Planning Association (ACT).

Wendy Copeland

Wendy Copeland has experience working as a laboratory scientist, document writer and quality control manager for Canberra Fertility Centre, and also as a teacher and pharmacist.

Qualifications:

Bachelor of Pharmacy, Curtin University 1984

Bachelor of Education, ACU 2000